David Baltimore

Insider Reports History

Location
Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA
Signature
/s/ Christopher Aker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Baltimore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Director Common Stock 0 $0 $7.87 Jun 25, 2025 By Spouse
Regulus Therapeutics Inc. Director Common Stock 0 $0 $7.87 Jun 25, 2025 Direct
Regulus Therapeutics Inc. Director Stock Option 0 Jun 25, 2025 By Spouse
Regulus Therapeutics Inc. Director Stock Option 0 Jun 25, 2025 Direct

Insider Reports Filed by David Baltimore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGLS Regulus Therapeutics Inc. Jun 25, 2025 18 $0 4 Jun 27, 2025 Director
RGLS Regulus Therapeutics Inc. Apr 30, 2025 2 $0 4 Apr 30, 2025 Director
RGLS Regulus Therapeutics Inc. Jan 30, 2025 1 $20.8K 4 Jan 31, 2025 Director
RGLS Regulus Therapeutics Inc. May 20, 2024 1 $0 4 May 21, 2024 Director
RGLS Regulus Therapeutics Inc. May 16, 2024 1 $0 4 May 17, 2024 Director
RGLS Regulus Therapeutics Inc. Aug 10, 2023 1 $0 4 Aug 14, 2023 Director
RGLS Regulus Therapeutics Inc. Jun 13, 2023 1 $0 4 Jun 13, 2023 Director
RGLS Regulus Therapeutics Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
RGLS Regulus Therapeutics Inc. Jun 14, 2021 1 $0 4 Jun 15, 2021 Director